SBFI-AM
Names
[ CAS No. ]:
129423-53-6
[ Name ]:
SBFI-AM
[Synonym ]:
S1148_SIAL
Sodium indicator SBFI-AM,Sodium-binding benzofuran isophthalate-AM
SBFI-AM
Sodium-binding benzofuran isophthalate-AM
Sodium indicator SBFI-AM
Biological Activity
[Description]:
[Related Catalog]:
[References]
Chemical & Physical Properties
[ Density]:
1.311g/cm3
[ Boiling Point ]:
1110.3ºC at 760 mmHg
[ Molecular Formula ]:
C56H58N2O23
[ Molecular Weight ]:
1127.06000
[ Flash Point ]:
625.3ºC
[ Exact Mass ]:
1126.34000
[ PSA ]:
289.31000
[ LogP ]:
6.74620
[ Vapour Pressure ]:
0mmHg at 25°C
[ Index of Refraction ]:
1.567
MSDS
Safety Information
[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
[ RIDADR ]:
NONH for all modes of transport
Articles
Nature Chemistry 6(10) , 885-92, (2014)
Anion transporters based on small molecules have received attention as therapeutic agents because of their potential to disrupt cellular ion homeostasis. However, a direct correlation between a change...
A neutrophil intrinsic impairment affecting Rab27a and degranulation in cystic fibrosis is corrected by CFTR potentiator therapy.Blood 124(7) , 999-1009, (2014)
Studies have endeavored to reconcile whether dysfunction of neutrophils in people with cystic fibrosis (CF) is a result of the genetic defect or is secondary due to infection and inflammation. In this...
Cyclooxygenase 2 inhibitor celecoxib inhibits glutamate release by attenuating the PGE2/EP2 pathway in rat cerebral cortex endings.J. Pharmacol. Exp. Ther. 351(1) , 134-45, (2014)
The excitotoxicity caused by excessive glutamate is a critical element in the neuropathology of acute and chronic brain disorders. Therefore, inhibition of glutamate release is a potentially valuable ...